<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04754022</url>
  </required_header>
  <id_info>
    <org_study_id>TRICS-IV</org_study_id>
    <nct_id>NCT04754022</nct_id>
  </id_info>
  <brief_title>Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery</brief_title>
  <acronym>TRICS-IV</acronym>
  <official_title>An International, Multi-centre, Randomized Controlled Trial to Assess Transfusion Thresholds in Younger Patients Undergoing Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Unity Health Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Unity Health Toronto</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      TRICS-IV is an international, multi-centre, open-label randomized controlled trial of two&#xD;
      commonly used transfusion strategies in moderate to high risk patients who are 65 years of&#xD;
      age or younger undergoing cardiac surgery on cardiopulmonary bypass, using a superiority&#xD;
      trial design.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2021</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite score of any one of the following events occurring 6 months after cardiac surgery: (1) all-cause mortality; (2) myocardial infarction; (3) new onset renal failure requiring dialysis; or (4) new focal neurological deficit (stroke).</measure>
    <time_frame>Within 6 months after cardiac surgery.</time_frame>
    <description>Any of all-cause mortality, myocardial infarction, new onset renal failure requiring dialysis, or new focal neurological deficit (stroke).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of each individual component of the primary outcome: all-cause mortality, myocardial infarction, new onset renal failure requiring dialysis, and new focal neurological deficit (stroke).</measure>
    <time_frame>Within 6 months after cardiac surgery.</time_frame>
    <description>Incidence of all-cause mortality, myocardial infarction, new onset renal failure requiring dialysis, and new focal neurological deficit (stroke).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite and individual all-cause mortality, myocardial infarction, new onset renal failure requiring dialysis, and new focal neurological deficit (stroke).</measure>
    <time_frame>Up to hospital discharge or after 28 days postoperatively, whichever comes first.</time_frame>
    <description>Composite and individual incidence of all-cause mortality, myocardial infarction, new onset renal failure requiring dialysis, and new focal neurological deficit (stroke).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in the ICU and hospital.</measure>
    <time_frame>Up to hospital discharge or after 28 days postoperatively, whichever comes first.</time_frame>
    <description>Length of stay in the ICU and hospital in days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prolonged low output state.</measure>
    <time_frame>Up to hospital discharge or after 28 days postoperatively, whichever comes first.</time_frame>
    <description>Defined as the need for two or more inotropes for 24 hours or more, intra-aortic balloon pump or ventricular assist device postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation.</measure>
    <time_frame>Up to hospital discharge or after 28 days postoperatively, whichever comes first.</time_frame>
    <description>Time on mechanical ventilation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of infection.</measure>
    <time_frame>Up to hospital discharge or after 28 days postoperatively, whichever comes first.</time_frame>
    <description>Defined as septic shock with positive blood cultures; pneumonia defined as autopsy diagnosis or roentgenographic infiltrate and at least two out of three of the following criteria: fever, leukocytosis, and positive sputum culture; and/or deep sternal or leg wound infection requiring intravenous antibiotics and/or surgical debridement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute kidney injury.</measure>
    <time_frame>Up to hospital discharge or after 28 days postoperatively, whichever comes first.</time_frame>
    <description>Defined by the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guideline - a 50% increase in serum creatinine within 1 week or a 26.5 mmol/L increase within 48 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delirium.</measure>
    <time_frame>Up to hospital discharge or after 28 days postoperatively, whichever comes first.</time_frame>
    <description>Confusion Assessment Method (CAM) or CAM-ICU (even on 1 occasion), or Intensive Care Delirium Screening Checklist (ICDSC) &gt; 3, or 3D-CAM, or 4AT ≥4, or more than one dose of haloperidol or similar antipsychotic drug, or documented delirium by neurologist or neurosurgeon or psychiatrist consultation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of gut infarction.</measure>
    <time_frame>Up to hospital discharge or after 28 days postoperatively, whichever comes first.</time_frame>
    <description>Confirmed by imaging (e.g. angiography), autopsy, or through surgical means.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital visits.</measure>
    <time_frame>Within 6 months after cardiac surgery.</time_frame>
    <description>Hospitalization and/or emergency visits and coronary revascularization after index procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfusion requirements.</measure>
    <time_frame>Up to hospital discharge or after 28 days postoperatively, whichever comes first.</time_frame>
    <description>The proportion of patients transfused and the number of blood products utilized (RBCs, plasma, platelets).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of seizures.</measure>
    <time_frame>Up to hospital discharge or after 28 days postoperatively, whichever comes first.</time_frame>
    <description>Generalized or focal tonic-clonic movements consistent with seizure; or electroencephalogram demonstrating epileptiform discharges; or diagnosis of seizures by neurologist or neurosurgeon consultation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of encephalopathy.</measure>
    <time_frame>Up to hospital discharge or after 28 days postoperatively, whichever comes first.</time_frame>
    <description>Unexpected delayed awakening or severely altered mental status (unconscious despite no sedative medication for more than 5 days), or encephalopathy documented by neurologist or neurosurgeon or psychiatrist consultation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1440</enrollment>
  <condition>Disorder</condition>
  <condition>Heart</condition>
  <condition>Postoperative</condition>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Restrictive Transfusion Strategy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive a RBC transfusion if their Hb concentration is &lt;75 g/L (&lt;7.5 g/dL; &lt;4.7mmol/L) intraoperatively and/or postoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liberal Transfusion Strategy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive a RBC transfusion if their Hb concentration is &lt;95 g/L (&lt;9.5 g/dL; &lt;5.9mmol/L) intraoperatively, or postoperatively in the ICU; and/or &lt;85 g/L (&lt; 8.5 g/dL; &lt;5.3mmol/L) on the ward.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Restrictive Transfusion Strategy</intervention_name>
    <description>Patients will receive a RBC transfusion if their Hb concentration is &lt;75 g/L (&lt;7.5 g/dL; &lt;4.7mmol/L) intraoperatively and/or postoperatively.</description>
    <arm_group_label>Restrictive Transfusion Strategy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Liberal transfusion strategy</intervention_name>
    <description>Patients will receive a RBC transfusion if their Hb concentration is &lt;95 g/L (&lt;9.5 g/dL; &lt;5.9mmol/L) intraoperatively, or postoperatively in the ICU; and/or &lt;85 g/L (&lt; 8.5 g/dL; &lt;5.3mmol/L) on the ward.</description>
    <arm_group_label>Liberal Transfusion Strategy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. ≥18 and ≤65 years of age&#xD;
&#xD;
          2. Planned cardiac surgery using cardiopulmonary bypass&#xD;
&#xD;
          3. Informed consent obtained&#xD;
&#xD;
          4. Preoperative European System for Cardiac Operative Risk Evaluation (EuroSCORE I) of 6&#xD;
             or more&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who refuse participation&#xD;
&#xD;
          2. Patients who are unable to receive or who refuse blood products&#xD;
&#xD;
          3. Patients who are involved in a preoperative autologous pre-donation program&#xD;
&#xD;
          4. Patients who are having a heart transplant or having surgery solely for an insertion&#xD;
             of a ventricular assist device&#xD;
&#xD;
          5. Pregnancy or lactation (a negative pregnancy test must be obtained prior to&#xD;
             randomization for women of childbearing potential)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Mazer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unity Health Toronto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nadine Shehata, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MOUNT SINAI HOSPITAL</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Interior Health Kelowna General Hospital</name>
      <address>
        <city>Kelowna</city>
        <state>British Columbia</state>
        <zip>V1Y 0C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nick Kuzak</last_name>
      <phone>250-808-3035</phone>
      <email>nick.kuzak@interiorhealth.ca</email>
    </contact>
    <investigator>
      <last_name>Nick Kuzak</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint John Regional Hospitall</name>
      <address>
        <city>Saint John</city>
        <state>New Brunswick</state>
        <zip>E2L 4L2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Craig Brown</last_name>
      <phone>506-648-6102</phone>
      <email>cdbrown@nbnet.nb.ca</email>
    </contact>
    <investigator>
      <last_name>Craig Brown</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hamilton Health Sciences Centre / Hamilton General Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Whitlock</last_name>
      <phone>905-521-2100</phone>
      <phone_ext>40306</phone_ext>
      <email>Richard.whitlock@phri.ca</email>
    </contact>
    <investigator>
      <last_name>Richard Whitlock</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Michael's Hospital, Unity Health Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Mazer, MD</last_name>
      <phone>416-864-5825</phone>
      <email>david.mazer@unityhealth.to</email>
    </contact>
    <investigator>
      <last_name>David Mazer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>February 9, 2021</study_first_submitted>
  <study_first_submitted_qc>February 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2021</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiac Surgery</keyword>
  <keyword>Transfusion</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

